Barkibu vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (39 vs 41)
Barkibu logo

Barkibu

EmergingPet Care

General

A Coruña Spain pet telemedicine + AI insurance (Munich Re) across 7 European countries at €50M turnover with 75K+ insured pets; BAI trained on 800K consultations with 80% retention competing with Agria for European pet health platform.

AI VisibilityBeta
Overall Score
D39
Category Rank
#464 of 1158
AI Consensus
88%
Trend
up
Per Platform
ChatGPT
40
Perplexity
40
Gemini
37

About

Barkibu is an A Coruña, Spain-based pet health and insurance platform — operating across seven European countries (Spain, Germany, France, Italy, Portugal, Greece, and Finland) with approximately €50 million in annual turnover and 75,000+ insured animals — providing pet owners with AI-powered veterinary triage, telemedicine consultations with licensed veterinarians, and comprehensive pet insurance underwritten by Munich Re that processes most claims automatically within minutes through proprietary AI. Barkibu's BAI (Barkibu Artificial Intelligence), trained on over 800,000 veterinary consultations, provides 24/7 symptom assessment for dogs and cats. The company projects reaching 125,000 insured pets by end of 2025 with an 80% customer retention rate, and won the EY Scale Up Award 2025 recognizing its exceptional growth trajectory. Founded in 2015 by Pablo Pazos, Patricia Seoane, Enrique Torres, Álvaro Gutiérrez, and María González; pivoted to AI-first model in 2018. Certified B Corporation.

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

39
Overall Score
41
#464
Category Rank
#220
88
AI Consensus
62
up
Trend
up
40
ChatGPT
49
40
Perplexity
36
37
Gemini
40
41
Claude
41
42
Grok
51

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.